Verapamil for type 1 diabetes

Recent research has shed light on a potential new avenue to reduce insulin requirements for people with type 1 diabetes. An estimated 1.2 million Australians...

Pharmacist remuneration to increase

0
PSA has been working to address one of the key issues raised by its members – remuneration – and is pleased to see the...

Bipolar disorder

Pharmacists are well placed to recognise early warning signs, support treatment adherence, and help improve patient diagnosis.

Massive jump in popular quit smoking app during pandemic

0
The number of Australians attempting to quit smoking has skyrocketed during the COVID-19 pandemic.

Adapting to digital health technologies

0
Nearly all Australian pharmacies are now registered for the My Health Record, following an increase in the use of technology brought about by the COVID-19 pandemic.

Behind the obsessions: a guide to obsessive-compulsive disorder

0
Obsessive-compulsive disorder is best managed with cognitive behavioural therapy, SSRIs and ongoing pharmacist support.